Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024

BUY
$60.14 - $75.36 $90,210 - $113,040
1,500 New
1,500 $97,000
Q1 2023

May 12, 2023

SELL
$46.12 - $65.71 $258,272 - $367,975
-5,600 Reduced 75.68%
1,800 $88,000
Q4 2022

Feb 13, 2023

BUY
$45.51 - $65.08 $146,451 - $209,427
3,218 Added 76.95%
7,400 $422,000
Q3 2022

Nov 07, 2022

BUY
$37.34 - $57.44 $156,155 - $240,214
4,182 New
4,182 $196,000

Others Institutions Holding IMCR

About Immunocore Holdings plc


  • Ticker IMCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,897,100
  • Market Cap $1.24B
  • Description
  • Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...
More about IMCR
Track This Portfolio

Track Quantbot Technologies LP Portfolio

Follow Quantbot Technologies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

News

Stay updated on Quantbot Technologies LP with notifications on news.